SCHEMBL21645971

SCHEMBL21645971

C#CCOc1ccnc(C=NO)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.46
TSHR P16473 1/20 0.46
LMNA P02545 1/20 0.46
KDM4E B2RXH2 1/20 0.44
ALOX15 P16050 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAOB P27338 8/20 0.38
HSP90AA1 P07900 1/20 0.37
MAOA P21397 4/20 0.37
ACHE P22303 1/20 0.37
GSTP1 P09211 1/20 0.36
CA12 O43570 3/20 0.35
CA4 P22748 3/20 0.35
CA9 Q16790 3/20 0.35
CA1 P00915 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21645970 1.00 HPGD (0.46) HPGDTSHRLMNAKDM4EALOX15
SCHEMBL21645923 0.80 GSTP1 (0.42) TSHRKDM4EMAOBMAOAACHE
SCHEMBL23909411 0.80 KDM4E (0.51) HPGDTSHRKDM4EALOX15L3MBTL1
SCHEMBL21645893 0.76 MEN1 (0.50) HPGDLMNAKDM4EALOX15L3MBTL1
SCHEMBL21645921 0.76 KDM4E (0.44) HPGDLMNAKDM4EALOX15L3MBTL1
SCHEMBL21645894 0.76 MEN1 (0.50) HPGDLMNAKDM4EALOX15L3MBTL1
SCHEMBL28313608 0.76 KDM4E (0.58) HPGDLMNAKDM4EALOX15L3MBTL1
SCHEMBL21645918 0.72 L3MBTL1 (0.54) LMNAKDM4EALOX15L3MBTL1HTT
SCHEMBL21645917 0.72 L3MBTL1 (0.54) LMNAKDM4EALOX15L3MBTL1HTT
SCHEMBL21645957 0.71 GSTP1 (0.44) TSHRKDM4EMAOBMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020027905-A2 ANALOGS OF 2-PRALIDOXIME AS ANTIDOTES AGAINST ORGANOPHOSPHORUS NERVE AGENTS UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2020-02-06 WO disclosed